Drugs / Apple Cider Vinegar
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial | ||||||
| Phase 0 | NCT05802121 | Jul 2025 → Sep 2026 overdue | diabetes mellitus, disease of bone structure, hyperlipidemia, metabolic syndrome X +2 | Western University | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05759442 | Jan → Apr 2023 | prediabetes syndrome | Bahria University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Apple Cider Vinegar | “Apple cider vinegar aimed at improving glycemic indices in Prediabetics” NCT05759442 ↗ |
| Known as | ACV | “Clinical Efficacy and Safety of Metformin Versus Apple Cider Vinegar (ACV) in Prediabetics” NCT05759442 ↗ |